US Congress Extends Funds For FDA, NIH, To Dec. 8 In Bill Linked To Hurricane Relief
Executive Summary
On the heels of a White House agreement with congressional Democratic leaders, the Senate and House quickly passed a government continuing resolution funding US FDA, NIH and other agencies as part of a Hurricane relief and debt-ceiling package, giving lawmakers until Dec. 8 to hammer out a detailed spending plan for the government in 2018.
You may also be interested in...
US FDA Device Funding Would Leap By 26% In 2019 Under Trump Budget Proposal
US FDA Device Center program funding would see a $131m increase under the Trump administration's budget proposal, which prioritizes "speeding innovations" in medical devices and other products the agency regulates, and closely examining what regulations need to be revised, updated or eliminated.
Medtech To Benefit From 20% Corporate Rate, Tax-Free Foreign Transfers In Pending US Tax Bill
Medical device firms will benefit from a Republican tax bill that has passed the full US House and a key Senate committee. The bill lowers the corporate tax rate to 20% from a maximum of 35%, treats foreign-earned intangible income at a favorably low rate of 12.5%, and permits tax-free transfers of intangible corporate property, such as patents, from foreign firms to US parents.
MDUFA IV (And More) Is Law: Trump Signs A Health-Care Bill
President Trump's eleventh-hour signature on the FDA Reauthorization Act puts into play about $1bn in device user-fee collections from industry through FY 2022, new US FDA performance goals and a range of device process enhancements and reforms supported by industry.